News | Cardiovascular Ultrasound | January 27, 2016

AMA Assigns New Investigational CPT Code for Myocardial Strain Imaging

Category III code meant to encourage further use of strain imaging in cardiology, cardio-oncology applications

AMA, investigational CPT code, myocardial strain imaging, cardio-oncology

January 27, 2016 — Effective Jan. 1, 2016, the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel assigned a new category III CPT code, 0399T, for use in reporting myocardial strain imaging for the detection of myocardial deformation. While Category III codes generally are not initially reimbursed, they often become payable when they are used routinely in clinical practice.

Research has shown that strain imaging can improve diagnostic assessment, standardize interpretation and assist in improving the monitoring of patients over time to optimize care. Additionally, measurements derived from strain imaging have been shown to be more sensitive and less variable than gold standard measurements like EF, making it increasingly important.

American Society of Echocardiography (ASE) chamber quantification guidelines now recommend strain imaging when assessing function. ASE recommendations for assessment and monitoring with echo of cardio-oncology patients indicate strain imaging should be monitored in this patient population.

The ACVI/ASE/Industry Task Force to Standardize Deformation Imaging issued definitions to improve standardization of 2-D speckle tracking measurements.

Increasingly, studies show that assessing and monitoring strain may improve quality of patient care and reduce costs with patient readmissions.

Although strain imaging has proven to be valuable in the assessment and management of patients with echo, until now, diagnostic software solutions with strain imaging have been research-oriented, laborious and workflow-inefficient in clinical practice.

EchoInsight is among the companies pushing for increased usage of strain imaging to improve diagnostic confidence, standardization and efficiency. Epsilon Imaging’s proprietary speckle tracking technology, TissueTrack, provides robust strain imaging with automation of cardiac functional measurements. It provides clinical strain imaging for improved confidence in assessment and monitoring of wall mechanics for the entire heart. It is available as a stand-alone workstation or client-server architecture using a vendor neutral platform.

For more information: www.epsilon-imaging.com

Related Content

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...